Lambert – Eaton syndrome associated with small cell lung cancer: a case report and diagnostic insights
https://doi.org/10.33667/2078-5631-2026-2-19-25
Abstract
The article presents a review of the current literature on paraneoplastic Lambert-Eaton syndrome (LES). A case report is provided, illustrating typical diagnostic challenges: initial misclassification as myasthenia gravis, lack of response to acetylcholinesterase therapy, the need to identify the «warm-up» phenomenon and rely on high-frequency repetitive nerve stimulation in the comprehensive electrophysiologic assessment of LES. It emphasizes that sustained oncologic screening is warranted when LEMS is suspected, even if initial imaging is negative, because neurological symptoms can precede tumor detection by months.
About the Authors
D. M. MerkulovaRussian Federation
Merkulova Dina M., Dr Med Sci (habil.), head, B. M. Guekht Neurology Center, Central Clinical Hospital “RZhD-Medicine”, I. M. Sechenov First Moscow State Medical University (Sechenov University); professor at Dept of Nervous Diseases, MEDSI Center of Excellence for Neuromuscular Diseases
Moscow
D. S. Lezina
Russian Federation
Lezina Diana S., neurologist, functional diagnostics physician
Moscow
A. N. Fedorova
Russian Federation
Fedorova Alsu N., neurologist
Moscow
E. L. Plieva
Russian Federation
Plieva Elizaveta L., neurologist
Moscow
E. A. Polyanskaya
Russian Federation
Polyanskaya Ekaterina A., neurologist
Moscow
Yu. A. Merkulov
Russian Federation
Merkulov Yuri A., Dr Med Sci (habil.), chief researcher at Pain Laboratory
Moscow
References
1. Rushkevich Yu.N., Trukhanov I.S., Pavlovskaya T.S. et al. Lambert–Eaton myasthenic syndrome: own clinical observation, literature review. Neurology and Neurosurgery. Eastern Europe. 2023; 13 (4): 497–508. (In Russ.). https://doi.org/10.34883/PI.2023.13.4.045
2. Sanadze A.G., Sidnev D.V., Shcherbakova N.I. et al. Lambert–Eaton myasthenic syndrome. S.S. Korsakov Journal of Neurology and Psychiatry. 2008; 108 (3): 4–10. (In Russ.). https://doi.org/10.17116/jnevro20171175177-80
3. Gabrusskaya T.V., Kornienko E.A., Revnova M.O. et al. Clinical observation of the development of Lambert–Eaton myasthenic syndrome in a patient with severe ulcerative colitis. Pediatrics im. G.N. Speransky. 2024; 103 (2): 102–106. (In Russ.). https://doi.org/10.24110/0031-403X-2024-103-2-102-106
4. Ivanisova A.V., Zabolotskikh N.V., Khatkhe Yu.A. et al. Diagnostic capabilities of studying the state of neuromuscular transmission in myasthenia and myasthenic syndromes. Kuban Scientific Medical Bulletin. 2018; 25 (1): 155–162. (In Russ.). https://doi.org/10.25207/1608-6228-2018-25-1-155-162
5. Shcherbakova N.I., Pikin O.V., Rudnichenko O.V. et al. A case of Lambert-Eaton myasthenic syndrome associated with asymptomatic small cell lung carcinoma. Neurological journal. 2024; (2): 11–17. (In Russ.). УДК: 616.747/.748–009.17–06:616.24–006.04]-03
6. Abenroth D.C., Smith A.G., Greenlee J.E. et al. Lambert-Eaton myasthenic syndrome: Epidemiology and therapeutic response in the national veterans affairs population. Muscle Nerve. 2017; 56 (3): 421–426. https://doi.org/10.1002/mus.25520
7. Ivanovski T., Miralles F. Lambert–Eaton myasthenic syndrome: early diagnosis is key. Degener Neurol Neuromuscul Dis. 2019; 9: 27–37. https://doi.org/10.2147/DNND.S192588
8. Giannoccaro M.P., Avoni P., Liguori R. Presynaptic paraneoplastic disorders of the neuromuscular junction: an update. Brain Sci. 2021; 11 (8): 1035.
9. Huddleston A., Nichols L. Educational Case: Lambert–Eaton syndrome. Acad Pathol. 2022; 9: 100021. https://doi.org/10.3390/brainsci11081035
10. Titulaer M.J. et al. Lambert–Eaton myasthenic syndrome: from clinical characteristics to therapeutic strategies. Lancet Neurol. 2021; 20 (10): 848–860. https://doi.org/10.1016/S1474-4422(11)0245-9
11. Alhammad R.M., Alsamlan Y., Alneseyan R. et al. Clinical presentations, electrophysiologic features, and long-term follow-up in Lambert-Eaton myasthenic syndrome: a series of six patients. Front Neurol. 2024; 15: 1525155. https://doi.org/10.3389/fneur.2024.1525155
12. Varon M.C., Dimachkie M.M. Diagnosis and treatment of Lambert-Eaton myasthenic syndrome. Pract Neurol. 2024: 26–29. https://practicalneurology.com/diseases-diagnoses/neuromuscular/diagnosis-and-treatment-of-lambert-eaton-myasthenic-syndrome/32113/
13. Graus F. et al. Paraneoplastic neurological syndromes: diagnosis and treatment. Nat Rev Neurol. 2022; 18 (5): 295–308. https://doi.org/10.1097/WCO.0b013e3282f189dc
14. Zang R.R., Han T., Guo F. et al. Lambert–Eaton myasthenic syndrome in a patient with small-cell lung cancer: a case report. Oncol Lett. 2015; 10 (3): 1339–1342. https://doi.org/10.3892/ol.2015.3473
15. Hulsbrink R., Hashemolhosseini S. Lambert–Eaton myasthenic syndrome: clinical update. Ther Adv Neurol Disord. 2023; 16: 1–15. https://doi.org/10.1016/j.clinph.2014.06.031
16. Maddison P. SOX1 antibodies in Lambert–Eaton myasthenic syndrome. J Neurol Neurosurg Psychiatry. 2022; 93 (3): 287–293. https://doi.org/10.1111/j.1749-6632.2012.06769
17. Sanadze A.G., Kasatkina L.F., Samoilov M.I. Use of Neuromidin in the Treatment of Peripheral Nervous System Diseases. Nervous Diseases. 2003; (3): 17–18. (In Russ.).
18. Wirtz P.W., Kuks J.B., Wintzen A.R. Presynaptic paraneoplastic disorders of the neuromuscular junction: an update. Ned Tijdschr Geneeskd. 2001; 145 (2): 57–61.
Review
For citations:
Merkulova D.M., Lezina D.S., Fedorova A.N., Plieva E.L., Polyanskaya E.A., Merkulov Yu.A. Lambert – Eaton syndrome associated with small cell lung cancer: a case report and diagnostic insights. Medical alphabet. 2026;(2):19-25. (In Russ.) https://doi.org/10.33667/2078-5631-2026-2-19-25
JATS XML
























